You are here

Article info

Article menu
XML
Basic tumor immunology
Original research
Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer

Authors

  • Byung-Seok Kim Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea Division of Life Sciences, College of Life Science and Bioengineering, Incheon National University, Incheon, South Korea PubMed articlesGoogle scholar articles
  • Da-Sol Kuen Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea BK21 program, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Choong-Hyun Koh Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Hyung-Don Kim Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Seon Hee Chang Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Sehui Kim Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea Cancer Research Institute, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Yoon Kyung Jeon Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea Cancer Research Institute, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Young-Jun Park Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea Department of Pharmacy, Jeju National University, Jeju, South Korea PubMed articlesGoogle scholar articles
  • Garam Choi Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Jiyeon Kim Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea BK21 program, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Keon Wook Kang BK21 program, College of Pharmacy, Seoul National University, Seoul, South Korea Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Hye Young Kim Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Suk-Jo Kang Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, South Korea PubMed articlesGoogle scholar articles
  • Shin Hwang Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Eui-Cheol Shin Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea PubMed articlesGoogle scholar articles
  • Chang-Yuil Kang Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Chen Dong Institute for Immunology and School of Medicine, Tsinghua University, Beijing, China PubMed articlesGoogle scholar articles
  • Yeonseok Chung Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea BK21 program, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yeonseok Chung; yeonseok{at}snu.ac.kr; Dr Byung-Seok Kim; byungseokkim{at}inu.ac.kr
View Full Text

Citation

Kim B, Kuen D, Koh C, et al
Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer
Journal for ImmunoTherapy of Cancer 2021;9:e002603. doi: 10.1136/jitc-2021-002603

Publication history

  • Accepted April 29, 2021
  • First published June 2, 2021.
Online issue publication 
February 24, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.